ABSTRACT 20 Gene regulatory networks (GRNs) with GATA factors are important in animal development, and 21 evolution of such networks is an important problem in the field. In the nematode, Caenorhabditis 22 elegans, the endoderm (gut) is generated from a single embryonic precursor, E. The gut is specified by 23 an essential cascade of transcription factors in a GRN, with the maternal factor SKN-1 at the top, 24
activating expression of the redundant med-1,2 divergent GATA factor genes, with the combination of 25 all three contributing to activation of the paralogous end-3 and end-1 canonical GATA factor genes. In 26 turn, these factors activate the GATA factors genes elt-2 and elt-7 to regulate intestinal fate. In this 27 work, genome sequences from over two dozen species within the Caenorhabditis genus are used to 28 identify putative orthologous genes encoding the MED and END-1,3 factors. The predictions are 29 validated by comparison of gene structure, protein conservation, and putative cis-regulatory sites. The 30 results show that all three factors occur together, but only within the Elegans supergroup of related 31 species. While all three factors share similar DNA-binding domains, the MED factors are the most 32 diverse as a group and exhibit unexpectedly high gene amplifications, while the END-1 orthologs are 33 highly conserved and share additional extended regions of conservation not found in the other GATA 34
factors. The MEME algorithm identified both known and previously unrecognized cis-regulatory motifs. 35 The results suggest that all three genes originated at the base of the Elegans supergroup and became 36 fixed as an essential embryonic gene regulatory network with several conserved features, although each 37 of the three factors is under different evolutionary constraints. Based on the results, a model for the 38 origin and evolution of the network is proposed. The set of identified MED, END-3 and END-1 factors 39 form a robust set of factors defining an essential embryonic gene network that has been conserved for 40 tens of millions of years, that will serve as a basis for future studies of GRN evolution. 41 42 INTRODUCTION 43 Central to the development of a metazoan is the activation of tissue-specific gene regulatory networks 44 (GRNs) that drive subdivision of progenitors and emergence of features of terminal differentiation 45 (DAVIDSON 2010 studies in embryogenesis is that the dissection of a GRN requires cause-and-effect associations to be 58 probed through experimental perturbations (DAVIDSON et al. 2002) . The powerful tools of forward and 59 reverse genetics in C. elegans have only recently become available in related species, most notably C. 60 briggsae, which like C. elegans is hermaphroditic and supports RNA-mediated interference (ZHAO et al. 61 2010). A third, and more important limitation, is that very few embryonic GRNs are known at high 62 resolution in C. elegans that could serve as a comparison. 63
The specification of the C. elegans endoderm is an example of a set of interacting transcription factors 64 that has been studied in great detail (MADURO 2017). In the early embryo, the founder cells E and MS are 65 born (Fig. 1A) . The E cell generates the entire endoderm (intestine), while its sister cell MS generates 66 many mesodermal cell types, including the part of the pharynx, and many body muscle cells (SULSTON et 67 al. 1983 ). Many components of the GRN underlying MS and E development are known with high 68 precision, and in most of cases, regulatory inputs have been confirmed to be direct and cis-regulatory elegans is through maternally provided PAL-1 protein, a Caudal-like factor whose primary role is 109 specification of a different blastomere called C (HUNTER and KENYON 1996; MADURO et al. 2005b) . 110 A small number of studies have investigated the evolutionary dynamics of gut specification in species 111 closely related to C. elegans. In C. briggsae, the end-1 and end-3 orthologues (the latter of which is 112 found as two nearby paralogues, end-3.1 and end-3.2) are expressed in the early E lineage, and 113 knockdown of both by RNAi results in a failure to specify gut (LIN et al. 2009; MADURO et al. 2005a ). In C. 114 briggsae and C. remanei, most orthologues of the med genes, when introduced individually as 115 transgenes, can fully complement the embryonic lethality of C. elegans med-1,2(-) embryos (COROIAN et 116 al. 2005) . Together these studies suggested that the med and end factors play similar roles in all three 117 species, as might be expected. Somewhat unexpectedly, however, knockdown of skn-1 and pop-1 118 orthologues in C. briggsae was found to produce different phenotypes from C. elegans, suggesting that 119 the way that SKN-1 and POP-1 interact with their downstream target genes is subject to evolutionary 120 changes even among very closely related species, i.e. the hallmark of developmental system drift (LIN et 121 al. 2009; ZHAO et al. 2010) . From these few studies, then, a model emerges of a core endoderm 122 specification pathway, where some regulatory inputs into the pathway are subject to more rapid 123 evolutionary change than others. 124
An important way that properties of a GRN can be studied on an evolutionary scale is to examine 125 features of orthologous genes in related species (PETER and DAVIDSON 2016 the med and end genes and their gene products, within and among closely related species, became 169 apparent, and these were used to refine the gene predictions. Searching of representative orthologs 170 from each species back to the C. elegans genome confirmed that the predictions were the best matches. 171
In some cases, the gene predictions from the assembly projects included short (<50 bp) predicted 172
introns that could also be read through as coding. For these, a case-by-case judgment was made as to 173
whether to include such introns in favor of maximizing amino-acid level homology. Some of the 174 predictions within less-conserved regions could be incorrect, but these would not be expected to 175 dramatically affect the analysis presented here. Similar judgments were made when multiple in-frame 176 start codons were possible at the 5' end of a gene, or when open reading frames could be extended in 177 the 3' direction by splicing around a stop codon. While no molecular validation of predicted genes was 178 made, the manual curation of gene predictions favoring maximal similarity of gene and protein 179 structures provides a surrogate validation by conservation across related species. This is the approach 180 taken computationally for gene predictions by algorithms such as TWINSCAN (KORF et al. 2001) . 181
It is highly likely that the gene set described here includes false duplicates. The quality and coverage of 182 the genome assemblies, as well as the maintenance of heterozygosity in sequenced strains, are known 183
to produce artifactual paralogues that are really alleles of one locus (BARRIERE et al. 2009; HAAG and 184 THOMAS 2015) . Some of these may still have been included as orthologues because they corresponded to 185 a predicted gene from the sequence assembly. For example, the two end-1 genes in C. brenneri are 186 nearly identical with one found on a small sequence scaffold, suggesting that there is only one end-1 187 orthologue in this species. The occurrence of these false duplicates is not expected to affect inter-188 species comparisons, for which a representative single gene/protein was chosen. Within a single 189 species, a false duplicate would appear as a pair of nearly identical proteins. Gene models categorized as 190 pseudogenes were more straightforward to find because they were truncated, had in-frame stop codons 191 or frame shifts in the DNA-binding domain, or were missing essential amino acids such as one of the four 192 cysteines in the C4 zinc finger. These may be expressed genes but were deemed unlikely to result in a 193 functional protein. 194 Comparison of the protein predictions to the gene predictions of the various sequence projects 195 validated the approach used to identify med and end orthologues. Of the genes identified and deemed 196 not to be pseudogenes, 94/174 (54%) were identical to a predicted CDS from the assemblies, 56/174 197 (32%) partially overlapped an existing CDS, and 24/174 (14%) did not correspond to a predicted CDS. 198
Differences from assembly project predictions often resulted from missing carboxyl and/or amino ends 199 because of large introns, or extensions of open reading frames that maximized ORF length only. 200 Completely missed predictions tended to be of the small intronless med genes that are often missed by 201 gene-finding algorithms. Reliance of cDNA sequence data were not found to be useful, likely because 202 the transient expression of the med and end factors in the earliest stages of embryogenesis meant that 203 med and end RNAs were generally absent from mixed-stage cDNA preparations. 204
Predicted genes/proteins have been provisionally named med-1.n/MED-1.n, end-3.n/END-3.n, and end-205
1.n/END-1.n (where n = 1, 2, 3, etc.). Lower numbers correspond roughly to the rank order of identified 206 high-scoring segment pairs from the TBLASTN search, which favors both stronger similarity with the C. 207
elegans search sequence and scaffolds that contain multiple hits. Where a single orthologue was found 208 in a species, it was named as med-1/MED-1, end-1/END-1 or end-3/END-3. For analyses where a single 209
representative of a set of paralogues was used, it was the first numbered one, except for pseudogenes 210 or one of the apparent two-fingered MEDs, in which case the next paralogue was used. 211
IDENTIFICATION OF CONSERVED REGULATORY MOTIFS 212
A representative set of promoters, one per Elegans supergroup species per factor, was compiled to 213 identify putative cis-regulatory motifs. This was done to reduce artifacts arising from overrepresentation 214 of sets of very similar promoters resulting from intraspecific paralogs, which tended to have very similar 215 promoters (data not shown). To identify sites starting with known binding sites, a JavaScript program 216 was written to count occurrence of sites and compute p-values assuming a Poisson distribution, after 217 the approach used in a prior work (MADURO et al. 2015) . To identify motifs ab initio by their 218 conservation, MEME (http://meme-suite.org/tools/meme) was used with expected site distribution with 219 any number of repetitions (anr), the number of motifs to be identified as 10, and a maximum motif 220 width of 12. Alternative parameters generally retrieved the same highly represented sites, except that 221 motifs with higher E-values (and hence less conserved) could be different. Searches of the end-1 and 222 end-3 promoters as separate groups produced qualitatively similar results as those that used both 223 together, except that MED-like sites became rare enough among the end-1 genes that they were not 224 reported as significant by MEME. I did not consider sites whose E-values were greater than 1e-02 as 225 these occurred among a small number of med and/or end genes. Some of these may represent less-226 conserved regulatory motifs, although they were not recognized as belonging to known factors from C. orthologues, the number of putative GATA factors in the genomes of species outside the Elegans 268 supergroup was smaller, typically 5 or fewer, and putative orthologues were better matched to other C. 269
Results

259
MED, END-3 AND END-1 ARE FOUND TOGETHER IN THE ELEGANS SUPERGROUP SPECIES
elegans GATA factors like ELT-3 (data not shown). Across the 20 species searched in the Elegans 270 supergroup, end-1 orthologs were unique in each genome except for C. brenneri (which has two end-1 271 genes), while multiple paralogs within a species was the norm for the end-3 orthologs with an average of 272 2.0 times per genome, and the med orthologues, found an average of 5.6 times. Of 208 genes identified, 273
34 were deemed to be the result of unresolved heterozygosity or were likely pseudogenes (counted 274 together under "pseudo" in Fig. 2 ); these were eliminated from further study. It is still likely that some 275 false duplicates persist in the predicted gene set, so occurrence of nearly identical paralogues should be 276
interpreted with caution (see Materials and Methods). In any event, the identification of false 277 duplicates would not change the results of inter-species comparisons, for which a single representative 278 gene was chosen for each factor. 279
CONSERVED LINKAGE OF end-1 and end-3 ORTHOLOGUES 280
In C. elegans and C. briggsae the end-1 and end-3 genes are within ~30 kbp of each other (MADURO et al. 281
2005a). Microsynteny of this type has been observed in other genes of these two species (COGHLAN and 282 WOLFE 2002; KENT and ZAHLER 2000) . To see if microsynteny of end-1 and end-3 is common, I examined 283
whether end-1 and end-3 orthologues in other species may be linked. As shown in Fig. 3A , in 12/18 of 284 the remaining Elegans supergroup species, end-1 and end-3 are found on the same scaffold with an 285 average separation of ~37 kbp and a range of 20-63 kbp. In C. brenneri, which has two end-1 and five 286 end-3 orthologues, one scaffold carries both an end-1 and an end-3, however the distance between 287 them is ~530 kbp. In the remaining five species, the end-1 and end-3 genes are found on different 288 scaffolds. Because it is possible for a sequence scaffold to break between two linked genes, there may 289 be additional synteny among these. For example, in C. sinica the scaffold containing the end-1 290 orthologue is 32 kbp in size with the end-1 gene located 3 kbp from one end, raising the possibility that 291 although its end-3 ortholog is on a different scaffold, end-1 and end-3 may be nearby in the genome. 292
Closely related species have similar patterns of end-1 and end-3 synteny, for example between C. afra 293 and C. sulstoni, and between C. zanzibari and C. tribulationis (Fig. 3A) . Although synteny is conserved, 294 the relative orientation of linked end-1 and end-3 paralogues varies, with examples of all four possible 295 linked arrangements. In C. elegans, end-1 and end-3 are encoded on the same strand with end-1 296 upstream of end-3. In C. sulstoni, two end-3 paralogs are upstream of end-1 with all three genes on the 297 same strand. In C. zanzibari and C. tribulationis, end-1 is on one strand in between two end-3 paralogs 298 on the other strand, hence in one end-1/3 pair the genes point towards each other, and in the other 299 they are divergently transcribed. These differing arrangements are consistent with the high rate of 300 intrachromosomal rearrangements previously noted for Caenorhabditis (COGHLAN and WOLFE 2002) . 301
PREVALENCE OF LINKED med AND end-3 DUPLICATIONS 302
In C. briggsae, two end-3 paralogues are found in an inverted orientation within several kbp, and in C. four of the Elegans supergroup species in Fig. 3B . In the most extreme case, 9/25 C. brenneri med 309 orthologs are clustered across a 23-kbp region, with an additional tandem pair located ~22 kbp away. 310
Linked duplications are therefore a common occurrence, particularly for the med genes. 311 were found to be intronless across the Elegans group, the meds from the Japonica group share a 321 common intron (indicated by an asterisk) within the C4 zinc finger coding region that is found in the 322 same position in all end-1 and end-3 genes. In addition to this conserved intron, within the Japonica 323 group, the C. japonica and C. panamensis med genes each have one more upstream intron at non-324 homologous positions. 325
ABSENCE OF A CONSERVED INTRON IN THE ELEGANS GROUP med GENES
DIFFERENCES IN INTRONS AMONG end-3 AND end-1 GENES 326
The conserved zinc finger intron is the only one shared between the end-3 and end-1 genes (Fig. 4A ). As 327 a group, the end-3 orthologs show the highest variability in the number of introns, with C. tropicalis 328 having only the one conserved intron, C. becei having four introns total, and the remaining species 329
having two or three. The end-1 orthologues are far less diverse, sharing the same four exons with three 330
introns, except for C. brenneri which is missing the second intron. In terms of size, the end-3 introns tend 331
to be smaller overall, with introns larger than 100 bp most apparent within the Elegans group end-1 332
genes. Hence, the positions of introns in the end-1 orthologues appear to be under a greater constraint 333 than those of the end-3 genes. 334
IDENTIFICATION OF CONSERVED PROMOTER MOTIFS 335
The occurrence of med and end genes in 20 related species affords the opportunity to identify 336 conserved cis-regulatory sites and infer conservation of the structure of the gut specification network. 337
The expectation is that conserved regulatory inputs found in C. elegans should be reflected in the 338 occurrence of similar cis-regulatory sites mediating the same promoter-DNA interactions in the other 339 species. I first searched for known binding sites for C. elegans factors among the Elegans supergroup 340 med and end orthologues using methods previously used in C. elegans (MADURO et al. 2015) . A size of 341 600bp upstream of the ATG was chosen for these and subsequent analyses, as the known regulatory 342
interactions Among the med upstream regions, I found only widespread conservation of SKN-1-like sites, and among 345 the end-3 orthologues, only MED sites (Supplemental Tables S1, S2 and S3). While these results support 346 conservation of activation of med orthologues by a SKN-1-like factor, and activation of end-3 orthologs 347 by MED-like factors, a complementary (and superior) approach is to search for over-represented motifs 348 ab initio. I therefore searched 600bp upstream of representative med and end genes from all 20 species 349 using the MEME discovery algorithm (BAILEY and ELKAN 1994). The results are summarized in Fig. 4B , with 350 the sites indicated by color coded circles on the promoters in Fig. 4A . The locations of the sites 351 diagrammed in Fig. 4 are listed in Supplemental File S1. 352
SKN-1 BINDING SITES IN THE med AND end GENES 353
Among the med orthologues, a motif resembling two overlapping SKN-1 sites was identified 19/20 354 species. The core of this motif, RTCATCAT, was found in two clusters in the C. elegans med genes and 355 DNA fragments containing these sites are capable of binding recombinant SKN-1 DNA-binding domain in 356
vitro (MADURO et al. 2001) . The same core is found in SKN-1 binding sites in gcs-1, a known SKN-1 target 357 gene in the fully developed intestine (AN and BLACKWELL 2003) . As in C. elegans, the SKN-1 sites in the 358 med genes are found within 300 bp of the predicted start site in most of the other species, which is 359 apparent from the diagram in Fig. 4A . In C. panamensis, which contains only a single putative med gene, 360
an RTCATCAT site was not identified by MEME although six 'core' RTCAT sites were found by direct 361 searching (p ≤ 0.05, Poission distribution). The low E-value of 1.1e-102 and presence of an average of 3.5 362 sites per species strongly suggest that activation of med orthologous genes likely occurs by SKN-1 in 363 most Elegans supergroup species. 364
Among the end-1 and end-3 genes, a TCATTYTCATC site was identified by MEME in 12/20 end-1 genes 365 and 14/20 end-3 genes (E-value 2.9e-11 
Sp1 BINDING SITES 373
A motif resembling the binding site for Sp1 was found in the med promoters (17/20 species, E-value of 374 2.0e-33), end-1 (20/20 species), and end-3 promoters (15/20 species), with an E-value of 4.8e-55 for the 375 two end genes. This same motif has been found among many C. elegans promoters, suggesting that 376 regulation by Sp1 is not restricted to gut specification (GRISHKEVICH et al. 2011). Reduction of function of 377 sptf-3, a gene encoding an Sp1-like factor, causes a decrease in specification of E and a reduction in 378 expression of end-1 and end-3 reporters (SULLIVAN-BROWN et al. 2016). From the widespread 379 conservation of the Sp1 binding sites, it is likely that Sp1 contributes to E specification across many 380 species in the Elegans supergroup through direct binding of the med, end-1 and end-3 orthologous 381 genes. 382
MED BINDING SITES IN THE end-1 AND end-3 GENES 383
Prior work identified the binding sites for the MED factors in the end-1 and end-3 genes, defining a core 384 sequence of AGTATAC that is distinct from the HGATAR This motif, consisting primarily of C and T, is most apparent among the Japonica group end-1 genes. relevance as a motif is uncertain, as in most of the end promoters that contain it, the site is more than 419 300bp upstream of the predicted start site. 420
PHYLOGENETIC ANALYSIS CONFIRMS THAT MED, END-3 AND END-1 FORM DISTINCT CLADES 421
The gene structure and promoter motifs suggest that the med, end-3 and end-1 genes form distinct 422 families among the 20 species of the Elegans supergroup. To confirm that this is reflected at the protein 423 level, I aligned the DNA-binding domains (DBDs) among representative MED, END-3 and END-1 factors 424 (one per species) and used this to construct a phylogenetic tree ab initio with the RAxML-NG method 425
( the factors increases confidence that the correct orthologues have been assigned and shows that 430 different rates of protein evolution have occurred among the three factors. 431
GENE AMPLIFICATION WITHIN AND AMONG SPECIES 432
While end-1 is represented by a unique orthologue among all species (except C. brenneri which may 433 have two end-1 genes), med and end-3 orthologues are often found as two or more duplicate genes 434 within a species. The two C. briggsae END-3 paralogues are highly similar, suggesting recent duplication, 435 and the multiple med genes among C. elegans, C. briggsae and C. remanei are also much more alike 436 cluster, the pattern suggests that both species inherited two or three med paralogues from a common 446 ancestor, which then each underwent further amplification post-speciation. Among the remaining 9 447 species that have 2-5 med genes each, the paralogous MEDs clustered together as a single group, 448
suggesting a single ancestral gene. This unusually widespread pattern of duplications both pre-and post-449 speciation, not seen in the end genes, shows that the med genes are under different evolutionary 450 constraints. 451 I note here that six genes were found that encoded MED-like factors with two C4 zinc fingers, indicated 452 on the tree in Fig. 6 . In each case, the two fingers were highly similar, so only one of the two fingers was 453 used to generate the tree. Four of the genes were present as two paralogous pairs in C. nigoni, one was 454 found in C. briggsae, and another was found in C. brenneri (Fig. 6 ). C. nigoni and C. briggsae are very 455 closely related, suggesting they inherited the same two-fingered med gene from a common ancestor 456
( A tree of the DBDs of the END-1 and END-3 orthologues is shown in Fig. 7 . As mentioned earlier, all END-462 1 orthologues are unique in each species except for the two possible end-1 paralogues in C. brenneri. 463
Among the END-3s, intraspecific amplification was implied for all species with two or more END-3s, 464 except for a cluster containing END-3 paralogues from C. sinica, C. tribulationis, and C. zanzibari. This 465 portion of the tree is most consistent with two paralogous end-3 genes having been present in the 466 common ancestor of all three species. Hence, duplications do occur among the end-3 paralogues, but at 467 a far lower frequency than with the med genes. 468
CONSERVED DOMAINS OF MED, END-3 AND END-1 469
Prior alignments of the ENDs from C. elegans and C. briggsae revealed three conserved domains: An reveal patterns of conservation of the gene structure in relation to these conserved regions. 478 479 An alignment of representative DBDs for the MED, END-3 and END-1 factors, one per species, is shown 480 in Fig. 9 (EDGAR 2004). Consistent with their recognizing an atypical binding site, the MED DBDs share 481
MED, END-3 AND END-1 DNA-BINDING DOMAINS
features that distinguish them from the END-3 and END-1 DBDs (Fig. 9A ). Among the Elegans group MED 482 factors, the C4 zinc finger has 18 amino acids between the two pairs of cysteines, with a structure of 483 CXXC-X18-CXXC, while the Japonica group members are diverged from this structure and have 16-17 484 amino acids, i.e. CXXC-X16-17-CXXC. A consensus sequence with 11 invariant amino acids is shown below 485 the alignment in Fig. 9A . While the group of MED factor DBDs appear to be diverse, the identification of 486 a conserved MED-like motif among the end-3 promoters suggests that the MED factors have 487 nonetheless coevolved to continue recognizing a similar binding site in each species. The solution 488
structure MEDs it is an arginine or a lysine (K), both of which are basic. The isoleucine (I) is not conserved, 495
however, and is replaced by a cysteine (C) in most other MEDs. This amino acid may not be critical for 496 recognition of a MED binding site, however, as prior work showed that transgenes containing individual 497
med genes from C. briggsae and C. remanei can fully complement the embryonic lethal phenotype of C. 498 elegans med-1; med-2 double mutants; in the MED factors from both of these species, the 499 corresponding amino acid is a cysteine. Overall, despite the higher divergence among the MEDs as a 500
group, there appears to be selection for the 8/9 amino acids known to be involved in site recognition in 501 C. elegans MED-1. Added to the apparent conservation of MED-like binding sites in the respective end-3 502 orthologues in every species, the data suggest maintenance of the DNA-binding specificity of the MEDs. 503
In contrast with the divergent MEDs, the DBDs of the END-3 and END-1 orthologues are more alike and 504
share greater similarity to those of canonical GATA factors. The ENDs, ELT-2 and cGATA have an 505
invariant CXXC-X17-CXXC zinc finger structure with 17 amino acids between the 2 nd and 3 rd cysteines. 506
Consensus sequences for END-3 and END-1, shown below the alignments in Figs. 9B and 9C, contain 23 507 invariant amino acids for END-3, and 31 for END-1, i.e. 2x and 3x more than the 11 invariant amino acids 508 among the MED DBDs. A solution structure for END-1 or END-3 has not been reported, but as a 509 surrogate I have shown, beneath both alignments, the 18 amino acids in the cGATA1 zinc finger known 510
to mediate base contacts (OMICHINSKI et al. 1993 ). END-3 is conserved at 7/18 of these positions with 4 511 amino acids being invariant, while END-1 has 10/18 positions conserved, of which 8 are invariant. Hence 512 the END-1s are structurally more like cGATA1 than are the END-3s, plus the END-1 orthologues are also 513 invariant at more positions, indicating that they are under the most evolutionary constraint. 514
An amino acid in the END-3 DBD is worth further comment. The proline between the 3 rd and 4 th 515 cysteines of the zinc finger, in sequence CNPC, was substituted by a leucine in the EMS-induced C. 516 elegans mutant end-3(zu247) (MADURO et al. 2005a) . This mutant has a phenotype indistinguishable 517 from the null mutant end-3(ok1448) which lacks most of the DBD (OWRAGHI et al. 2010). While this 518 position is also a proline in 12/20 species, among the other END-3s it is serine (S) or alanine (A). Serine 519 has a short polar side chain, while alanine is short and hydrophobic, however leucine is also hydrophobic 520 but longer, suggesting that the longer side chain at this position compromises the structure of the zinc 521
finger. This position is variable among the MED and END-1 orthologues, where it is a proline (P), alanine 522 (A), serine (S), or glycine (G), indicating this position is under relaxed selection. 523
Another difference between the END-3s and END-1s is the amino end of the C4 zinc finger between the shown with ELT-2 and cGATA1 in Fig. 9D , showing that all three factors share conserved amino acids 531
with each other and with canonical GATA factors. Overall, 7/18 of the amino acids known to mediate 532
DNA recognition in cGATA1 are broadly conserved (OMICHINSKI et al. 1993) . 533
SERINE-RICH DOMAINS IN MEDs AND ENDs 534
The MED and END factors share an upstream region of variable size enriched in the polar amino acids 535 serine, with or without threonine. These are shown diagrammatically in Fig. 8 , as the amino-most 536 conserved domain among the MEDs and ENDs, and in amino acid sequence alignment in Fig. 10A . 537
Among the MEDs, the Poly-S/T region is variable in size, consists of both serines and threonines, and is 538 the only other conserved feature upstream of the DNA-binding domain. Because of the size variability, 539
the alignment in Fig. 10A represents only part of an overlapping region among MEDs of all 20 species. 540
Among the ENDs, a similar Poly-S domain, consisting almost exclusively of homopolymeric clusters of 541 serines, is found at the amino terminus starting at the 3 rd or 4 th amino acid (Fig. 10A ). In one exception, 542
the Poly-S domain is all but gone in C. japonica END-3. As noted earlier, the Poly-S region had been 543
previously 
CONSERVATION OF THE END FAMILY GATA DOMAIN (EGD) 553
Previous work identified the END family GATA Domain, or EGD, immediately upstream of the C. elegans 554 and C. briggsae END-1 and END-3 DBDs (MADURO et al. 2005a ). This domain does not occur among the 555 other C. elegans GATA factors, suggesting it is uniquely important for function of END-1 and END-3. 556
Among the 20 species in the Elegans supergroup, the END-1 and END-3 orthologues across 20 species do 557 contain a conserved region immediately upstream of the zinc finger. This is shown diagrammatically in 558 Fig. 8 , and by sequence alignment in Fig. 10B . Whereas the original report had the domain consisting of 559 the 9 amino acids, an extended domain is apparent that consists of approximately 25 amino acids. 7 of 560 these (shown by an asterisk in the figure) are highly conserved between the END-3 and END-1 factors, 561 but there are conserved amino acids within each group of factors, plus the domain is more conserved 562 among the END-3 orthologues. While the EGDs tend to be enriched in basic amino acids, their 563 significance remains unknown. 564
END-1 SPECIFIC DOMAINS 565
Among the END-3 orthologues, the region between the Poly-S and the EGD regions is variable in size and 566
does not exhibit sequences with extensive conservation (Fig. 8) . In contrast, the END-1 orthologues 567 display three additional domains that are highly conserved across all 20 species (Figs. 8 and 10C) . A 568 consensus sequence shows high conservation with many invariant regions. These domains are 569 apparently novel, as a BLAST search using this region of END-1 did not identify related proteins other 570 than predicted orthologues of END-1 within Caenorhabditis. With the identification of these extended 571 sequence similarities, the END-1 orthologues across the 20 species are highly conserved throughout 572 their lengths, while the END-3 and MED orthologues are conserved only in parts. supergroup that originated in a common ancestor. 588
HIGH RATES OF MED GENE DUPLICATION 589
The med, end-3 and end-1 genes showed distinct patterns of gene duplication among species. 590
Occurrence of duplicate med genes is disproportionately high, with an average of 5.6 med genes per 591 species, compared with 2.0 end-3 genes and a single end-1 per species, except for C. brenneri which may 592 have two end-1 genes (Fig. 2) . In most cases, sequence similarity was consistent with most med 593 duplicates having arisen post-speciation, with the only exceptions resulting from likely inheritance of 594 two med genes in a recent common ancestor (Fig. 6 ). 595
The apparent recent amplification of the meds suggests that there is ongoing selective pressure for 596 increased med expression. The occurrence of MED binding sites in the end genes (particularly end-3) 597
argues for positive selection for the presence of these sites, and hence the MED factors that can bind 598 them. Selection for increased med expression is supported by work showing that C. elegans has an 599 unusually high rate of segmental duplications compared with other species, with a higher gene dose 600 generally leading to increased mRNA production (KONRAD et al. 2018). In C. elegans, a single 601 chromosomal med gene is sufficient for completely normal development (MADURO et al. 2007 ). 602
However, C. elegans has only two med genes. Perhaps in some of the other species, the MED factors 603
have become degenerate in their ability to activate target genes, or to be activated. Protein degeneracy 604 would be consistent with the lower degree of protein sequence conservation among the MED DNA-605
binding domains in C. brenneri, which has experienced an extreme amplification of med genes ( Fig. 9 ). 606
However, that does not explain amplification of med genes in C. doughertyi, whose MED DNA-binding 607 domains are more similar as a group, unless they are collectively degenerate in some way ( Fig. 9 ). 608
Regardless of the mechanism driving MED amplification, there is support for reduced fitness if MED-609 dependent input into endoderm specification is compromised. Recent work has found that loss of MED ). Hence, whatever mechanism driving is increased med dosage may 614 not be due to the role of the MEDs in gut specification. 615
LINKAGE OF END ORTHOLOGUES 616
In most species, end-1 was found within ~35 kbp of end-3 (Fig. 3A) . One possibility for maintenance of 617 this synteny is that the two genes may be coregulated. Three lines of evidence argue against this 618 possibility, at least for C. elegans. First, there is at least one unrelated gene between the ends, the . It may be, therefore, that synteny 624 of end-1 and end-3 merely reflects their origin as a tandem duplication of an ancestral end gene. 625
IDENTIFICATION OF KNOWN AND PREVIOUSLY UNRECOGNIZED cis-REGULATORY SITES 626
The MEME search recovered binding sites for regulators previously known to activate the med and end 627 genes in C. elegans (Fig. 4B ). In the case of the med orthologues, this was binding sites for SKN-1, while 628
for the end genes, it was binding sites for both SKN-1 and MED-1. The conservation of these sites 629 supports the hypothesis that these genes have maintained the same regulatory hierarchy as in C. 630 elegans, with SKN-1 activating the med genes, and both SKN-1 and the MED proteins activating the end 631 genes. The MED sites in the Elegans supergroup end genes are found in all end-3 orthologues but only 632 9/20 end-1 orthologues, following the same pattern as in C. elegans: end-3 has four MED sites and these 633 are collectively essential for end-3 activation, although even a single MED site in a single-copy end-3 634 transgene is sufficient for activation (MADURO et al. 2015) . In contrast, end-1 has only two MED sites, and 635 these are less important for end-1 expression due to parallel input by TCF/POP-1 and PAL-1 (MADURO et 636 al. 2015; MADURO et al. 2005b ). The likely sites for SKN-1 in end-1 and end-3 were not previously known 637 because they do not contain the same pattern of SKN-1 site core sequences as present in the med 638
promoters. An intriguing hypothesis is that the SKN-1 sites in the end genes may be of lower affinity 639 than those in the med genes. Because expression of the end genes is delayed by at least one cell cycle 640 compared with med-1,2, lower-affinity SKN-1 sites could potentially allow for delayed activation. A 641 similar affinity difference has been hypothesized for early-and late-acting binding sites of the pharynx 642 regulator PHA-4 (GAUDET et al. 2004 ). As the SKN-1 sites in the end genes were not found in all species, it 643 is possible that the input from SKN-1 is lost in some species. Finally, an additional suspected regulatory 644
input was from an Sp1-like factor, likely to be SPTF-3 (SULLIVAN-BROWN et al. 2016) . Most of the med, 645
end-3 and end-1 orthologues have a consensus Sp1 binding site (Fig. 4B) . Together, the recovery of these 646 sites from an ab initio search of their putative promoters lends strong support to the hypothesis of 647 conservation of this gene network across the Elegans supergroup. 648 MEME-identified sites of lower significance, and not as broadly conserved, were either unknown or 649 reflected putative core promoter elements. These include one with core sequence TCTKCAC, a 650 polypyrimidine motif, putative PolyA/T cluster, a TATA-binding protein (TBP) site, and an SL1 motif. The 651 latter two were previously found in many promoters in five Elegans supergroup species ( med genes, hence it is possible to test its significance directly. The site was found three times close to 655 the previously identified SKN-1 sites, suggesting it may play an accessory role to SKN-1 activation, 656 perhaps by SKN-1 itself. 657
What was particularly conspicuous was that sites for minor regulatory inputs known in C. elegans were 658 not found to be widely conserved, either by a direct search or through MEME. CLEUREN et al. 2019 ). An emerging model seems to be that the core SKN-1 670
 MED  END-1,3 regulatory cascade is conserved, while additional regulatory inputs that reinforce 671 this cascade evolve rapidly and would thus be expected to be species-specific. Putative cis-regulatory 672 sites that mediate these supporting inputs might therefore occur in only a subset of species in the 673 Elegans supergroup and would be missed in the analysis done here. 674
END-3 AND END-1: THE SAME BUT DIFFERENT 675
In C. elegans, end-1 and end-3 clearly have overlapping function. Complete loss of both genes has a fully 676 penetrant failure to specify endoderm, while null alleles either for gene alone have either no effect (end- orthologues are clearly more similar to each other than they are to the MEDs (Figs. 5, 9 ). 682
Despite these similarities, END-3 and END-1 differ in ways that suggest they have at least some unique 683 functions. First, the END-1 DBDs are more highly conserved as a group, while those of END-3 are under 684 slightly more relaxed selection. This is apparent in the way that the DBDs appear in a phylogenetic tree 685 ( Fig. 7) and in the degree of invariant amino acids in an alignment (Figs. 9B, 9C ). Within their DBDs, the 686 END-1s have twice as many similar amino acids in common with vertebrate cGATA1 than the END-3s 687 have in common with cGATA1, notably in acid positions known to mediate sequence recognition (Figs. 688 9B, 9C). 689
Additional evidence is consistent with both shared and divergent activity of END-3 and END-1 in C. but many more that are unique to either EGD (Fig. 10B ). Although the function of the EGDs remains 697 unknown, their conservation and proximity to the DBDs suggest an accessory role in protein-DNA 698
interactions that is unique to the ENDs among the Caenorhabditis GATA factors. 699
THE POLY-S REGION OF END-3 AND END-1: PROTEIN DOMAIN OR POLYPYRIMIDINE TRACT? 700
END-3 and END-1 share an amino-terminal segment, far from the DNA-binding domain, that is enriched 701 for homopolymers of serine (Fig. 10A) However, it is not clear why there would be selection to delay translation of end mRNA, particularly as 717
given the rapid early cell divisions of the C. elegans embryo, it makes more sense to express the gene 718 products as rapidly as possible. A more benign reason for the maintenance of the serine codon repeats 719 is that they are an artifact of a trinucleotide repeat expansion process (KOREN and TRIFONOV 2011). 720
Indeed, in that study, amino acid repeats in vertebrate proteins were most likely to be found in the first 721 exon, i.e. at the amino end, consistent with their location in the end-3 and end-1 genes. Hence, the role 722 of the Poly-S domain, if any, remains open for speculation until structure-function studies are 723 performed. 724
END-1 ORTHOLOGUES ARE CONSERVED THROUGHOUT THEIR LENGTHS 725
An additional unexpected finding emerged from the alignment of END-1 orthologues that distinguishes 726 them among the MED/END proteins. Between the Poly-S and EGD domains, the END-3 orthologues as a 727 group were diverse in size and sequence, whereas the END-1 orthologues were more similar in size and 728
showed several regions of high conservation (Fig. 10C) . These END-1-specific domains could be grouped 729 into three regions containing blocks of invariant amino acids. The most striking of these is the center 730 domain which contains an invariant sequence of FGQYF across all species END-1s. None of these highly 731 conserved domains are found in other proteins, apart from predicted END-1 orthologues. The high 732 conservation is further supported by the conservation of introns. The END-1s have four introns with only 733 one of these absent in C. brenneri (Fig. 4A) . In contrast, the END-3s were more likely to experience 734 intron gains and losses over the same evolutionary time period, with most of these occurring in the 735 variable region between the amino-terminal Poly-S and EGD domains (Fig. 8) . A cursory examination of 736 the amino acids in the END-1-specific domains suggests that these are on the outside of the protein, 737 perhaps mediating protein-DNA or protein-protein interactions that do not occur with END-3 (data not 738 shown). 739
Taken together, these data show that across the Elegans supergroup, the END-1s are highly conserved 740 proteins with greater similarity to vertebrate GATA factors than the more diverse END-3s paralogues. 741
This predicts that END-1 has unique features in transcriptional activation, and that the target genes 742 activated by each of these factors are likely to include both and distinct targets. 743
MED ORTHOLOGUES: A DIVERGENT AND DIVERSE SUBCLASS OF GATA FACTORS 744
The MED orthologues among the 20 species were found to be divergent from the END-3/END-1 factors, 745
and to comprise a more diverse group of proteins themselves, even within the DNA-binding domain 746 (Figs. 5, 9 ). The divergence of the DBD from that of the ENDs, ELT-2 and cGATA is expected, because the 747 C. elegans MEDs were recognized to be divergent GATA factors that recognize a different binding site 748
with an AGTATAC core (BROITMAN-MADURO et al. 2005; LOWRY et al. 2015) . Despite the high divergence of 749 the MED factors as a group, indicating relaxed selection, there is nonetheless maintenance of their 750 binding site sequence over evolutionary time. This is supported by the conservation, across all 20 751 species, of most of the amino acids that were found to mediate protein-DNA recognition in C. elegans 752 MED-1 (Fig. 9A) , and more importantly, by the MEME identification of AGTATAC binding sites among all 753 end-3 orthologous genes and 9/20 end-1 genes (Fig. 4) . Furthermore, transgenes of most of the C. 754
briggsae and C. remanei meds were individually able to complement C. elegans med-1,2 double mutants 755 in both gut and mesoderm specification despite limited conservation (COROIAN et al. 2005) . Selection is 756
likely not acting solely on the MEDs for end gene activation, as there are other direct MED targets in C. 757 elegans whose orthologues in the Elegans supergroup were not investigated here, including in the early 758 MS lineage (BROITMAN-MADURO et al. 2006; BROITMAN-MADURO et al. 2005) . The lower conservation 759
suggests that the MED DBDs may simply be more accommodating of amino acid substitutions than are 760
the DBDs of END-3 or END-1. 761
Outside of the DNA-binding domain, the MEDs as a group lack the type of conserved regions seen in the 762
ENDs. The only other feature found is a variable enrichment for serine and threonine of unknown 763 significance. This region does not resemble the homopolymeric enrichment for serine that is at the 764 amino end of the ENDs (Fig. 10A ). Rather, it is a higher prevalence for S/T that lacks a recognizable 765 context. A serine-threonine rich motif was found to be important for nuclear localization of the 766 mineralocorticoid receptor in vertebrates, suggesting that this region of the MED orthologs may play a 767 similar role (WALTHER et al. 2005) . Until structure-function analyses are done, the significance of the 768 serine/threonine enrichment will remain unknown. 769
THE MED/END CASCADE IS A DERIVED CHARACTER 770
The existence of a gut-like precursor is a conserved lineage feature found in more distantly related 771 nematode species (HOUTHOOFD et al. 2003; SCHIERENBERG 2006 ; SCHULZE and SCHIERENBERG 2011). It must 772 therefore be that species outside the Elegans supergroup specify the gut precursor without MED/END 773 factors. The most upstream factor SKN-1, and the downstream gut identity factor ELT-2, are also more 774 widely conserved than just the Elegans supergroup (COUTHIER et al. 2004; SCHIFFER et al. 2014) . Assuming 775 that SKN-1 still specifies MS and E, the simplest hypothesis is that specification of gut outside of the 776 Elegans supergroup occurs by direct activation of an elt-2-like gene directly by SKN-1. An attempt to 777 demonstrate bypass of the end-1 and end-3 genes was successful using an elt-2 transgene under 778 regulatory control of the end-1 promoter in a C. elegans strain lacking end-1 and end-3 (WIESENFAHRT et 779 al. 2015). However, this transgene worked best in a high copy-number array, and not in single-copy. 780
Furthermore, expression of this transgene is likely to be at least partially dependent upon regulatory 781 input by MED-1,2, based on studies with an end-1 promoter lacking MED binding sites (MADURO et al. 782 2015). As an alternative to direct SKN-1  ELT-2 regulation, there could be one or more non-GATA 783 regulators between them, analogous to the MED/END cascade. Regardless of how gut specification 784 occurs outside of the Elegans supergroup, some set of evolutionary events must have set in motion a 785 breakdown of the ancestral specification mechanism, favoring the evolution and fixation of the SKN-786 1/MED/END cascade as the dominant mode of E specification. 787
EVOLUTIONARY ORIGIN OF THE SKN-1  MED  END-1,3 CASCADE 788
The co-occurrence of the MED and END factors suggests that these genes evolved within a short time at 789 the base of the Elegans supergroup ( Fig. 11A) . At the start of this work there was an expectation that 790
there might have been one or more "transitional" species with only the end-3 and end-1 factors, or only 791 one end-like factor, for example. Since no such species were found, it may be that a transitional species 792 has not yet been sequenced, or that the orthologues are highly diverged. The reduced number of 793 recognizable GATA factors in species outside of the Elegans supergroup argues against this possibility, 794 however. 795
The data strongly suggest that the med and end genes might have been derived from the same ancestral 796 gene. This hypothesis is supported by the existence of an intron in the zinc finger domain of all med and 797 end genes, except for the Elegans group med genes where loss of this intron occurred. In the genus, 798
intron loss is common, and occurs more frequently than intron gain (ROY and PENNY 2006). One 799 mechanism by which this particular intron could have been lost is through germline gene conversion 800 from a reverse-transcribed (spliced) mRNA (ROY and GILBERT 2005). An alternative mechanism could be 801 through microhomology-mediated end joining, or MMEJ, of a double-stranded break in the gene (MCVEY 802 and LEE 2008; VAN SCHENDEL and TIJSTERMAN 2013) . Indeed, in one of the C. japonica med genes, a short 803 stretch of six base pairs upstream of this intron recurs close to the 3' splice site of the intron itself, such 804 that a repair of a double-stranded chromosome break by MMEJ would result in an in-frame removal of 805 the intron (Fig. 11B ). This would also require that the asparagine codon (AAC) is somehow maintained, 806
which may be possible given the observed types of MMEJ repair of double-stranded breaks induced by 807
Cas9 cleavage, e.g. (TAHERI-GHAHFAROKHI et al. 2018). Regardless of the mechanism, loss of this intron 808 likely occurred only once in the last common ancestor to the Elegans group. I note in passing that the 809 converse property, lack of intron gain in the Elegans group med genes, may be accounted for by 810 selection for rapid gene expression through avoidance of mRNA splicing; most early zygotic Drosophila 811 genes are in fact intronless (GUILGUR et al. 2014 ). However, a small number of the med gene predictions 812 in the Elegans supergroup do have introns (Supplemental File S1). 813
The structural conservation among the 20 Elegans supergroup MEDs and ENDs lead me to propose a 814 model by which the MED/END cascade arose through duplication and modification of existing genes, 815 from elt-2 upwards, as shown in Fig. 11C . The similarity of the END-3 and END-1 orthologs and their 816 tendency to be <50 kbp apart in a species suggests that they originated from a common progenitor 817
together, or that one was a duplicate of the other. Considering the stronger resemblance of the DNA-818 binding domain of END-1 with that of ELT-2 and vertebrate cGATA1, a reasonable hypothesis is that end-819 1 originated first, as a duplicate of an ancestral elt-2 gene that was both activated by SKN-1 and 820 maintained its own expression through positive autoregulation. Positive autoregulation of ELT-2 is 821 known and has even been visualized in vivo (FUKUSHIGE et al. 1999 end-1. Lending support for elt-2 as a progenitor for the end genes is the presence of the conserved zinc 828
finger intron found in all end-1/3 orthologues and in C. elegans elt-2/7. The two end genes could be 829 stabilized by the complete loss of SKN-1 sites in the elt-2 promoter, degeneracy of SKN-1 sites in the 830 end-1 promoter, and coevolution of END-3 with binding sites in the end-1 promoter. In this state, end-1 831 acts to amplify input into elt-2 from end-3. 832 A challenge is in accounting for the origin of a med-like progenitor, given the evidence that they form a 833 structurally divergent set of regulators. In this work it was found that while the Elegans group species 834 have intronless med genes, obscuring their origin, the putative Japonica group meds share a common 835 intron in the zinc finger coding region that is in the same location as the aforementioned intron in all 836 extant end-3 and end-1 genes. This leads to the hypothesis that a prototype med gene arose as a 837 duplicate of one of these genes, the most logical of which may be end-3. Co-evolution of the MED DNA-838
binding domain with cognate sites in end-1 and end-3 would reduce autoregulation of the end genes 839
and fix the MED factor within the network, though END-3 could retain the ability to contribute to end-1 840
activation. Degeneration of the SKN-1 sites in end-3 would strengthen the feed-forward cascade. Further 841 refinement of the network would strengthen regulatory input of the meds by SKN- into A/P specification in Drosophila likely required more steps than the MED/END cascade, because from 857 the proposed model, the cascade originated through duplication and modification of a factors already in 858 an ancestral version of the network. Hence, it is plausible that emergence of the MED/END network 859 could have occurred at the base of the Elegans supergroup. Furthermore, in analogy to Bcd, the initial 860 evolution of the MED DBD that resulted in a change in its binding site to a non-GATA target site might 861 have been driven by a small number (or even just one) key amino acid change. With the sequences of 862 med genes from 20 species, such structure-function correlations can now be examined. 863
Studies on the evolution of Bcd suggest a possible explanation as to why a more layered gene cascade 864 might have evolved for embryonic gut specification within the Elegans supergroup. The emergence of 865
Bcd may have conferred a more rapid specification of segment identity, allowing developmental time to 866 become faster without sacrificing robustness (MCGREGOR 2005) . By extension to the Elegans supergroup, 867 it is possible that the SKN-1  MED  END-1,3 gene regulatory cascade coincided with an increase in 868 developmental speed in Caenorhabditis, perhaps as part of the transition to very early and rapid cell fate 869 specification (LAUGSCH and SCHIERENBERG 2004; SCHIERENBERG 2001) . Elucidation of gut specification 870 mechanisms in Caenorhabditis species outside of the Elegans supergroup, compared with their 871 developmental speed, could provide evidence for this hypothesis, or alternatively identify non-GATA 872 factors that play the same role as the MED/END cascade. 873
In the meanwhile, the identification of MED, END-3 and END-1 orthologues in 20 species sets the stage 874 for studies to test hypotheses about evolution of gene regulatory networks, structure-function 875 correlations in the evolution of novel DNA-binding domains, and features of developmental system drift. 876
As the study of gene regulatory networks becomes more computational, the set of MED and END 877 orthologues identified here will provide a basis for future studies integrating gene network architecture 878 with transcriptomics data, for example (NOMOTO et al. 2019; OMRANIAN and NIKOLOSKI 2017 which contained no orthologues of the MED and END factors, have been omitted for simplicity. Table  905 cells are colored by the number of orthologues. 906 complement from the MEME output files in Supplemental Files S13 and S14. 917 immediately upstream of the zinc fingers of END-3 and END-1. A consensus sequence is shown beneath 949 each alignment, with amino acids similar between END-3 and END-1 shown with an asterisk (*). (C) 950
Highly conserved regions among the END-1 factors showing highly conserved amino acids and a 951 consensus sequence beneath the alignment. 952 Supplemental Files S2-S12. FASTA files containing protein and promoter sequences. 969
Supplemental Files S13 and S14. MEME output HTML files. 970
Supplemental Tables S1, S2 and S3. These tables contain search results for known cis-regulatory sites. 971 3  13  1  0  1  1  0  1  8  2  10  3  0  3  1  0  1  5  0  5  2  0  2  1  0  1  2  0  2  2  2  4  1  0  1  2  0  2  2  0  2  1  0  1  1  0  1  2  1  3  1 
SKN
F S E S S A S T Q D F S S F N M E N S P Q N R K H Q S F P D P D P T P L S S P V S V T G P V T P P P P Q P N P M T P W T Y A H S S P S S S A E A V P S P T S I P V L P D S P N F S S P S T S T V S P V F P S S V S F P S T S S T H N S S P V S T S S S T P S T A P S N F P G L Q N F W T S C P N F I A T P S T S T P P A S F P G S Q N F W T S Y P S F M A T P P L T S P P S E A P G P S S P G Y I E V T S S E S P P T P S E P S S F T N P N Y T P T D S G S M C S T P S S S C P S T H F S T P S T S P S T S T Q S S T T P S N S D N K K A P Q Y L S S A Y F L T P T P S N S P P T H S S E L V M N G S P I T Q V H Y P H A A P T P P S Q Q Q S T S S A S P S E S T K S D G L R D L K P K I S R I T Y T P P M P T S T F A T P N T S S A F S S T A T P S S T P P M P T S T F T T P N T S S T L S S T A T P C P N S P S T S S T L A P V Q L S A D V P I P S T N T L S S S P S S S S T G F T P F S A N S P T M P T P A F S P F T S T S P C S T S G T S T S S P P S T E S M S G F Q T P E S L P T T P G S S S S T P P G P Q L S D S L P T S P T T S T S S T S T T E S P S F V M P S T
VD KE G VV HRH EM RF S AN HG R PE P LF YD Y VD KH G VV HRH EM RF A AN HG R PD P YF YE Y -Q KD G VK YRE EM HF G PN HG N PS P YF YE Y -Q KD G VK YRE EM HF G PN HG N PS P YY YD Y -E KD G VK HRE EM HF A PN HG N PS P YY YE Y -M KD G VV KRE EM HF G PN HG N PS P YT YG I ID KN G VL HSH EM HF S QN HG N PS P YT YG V ID KD G KV HPH EM RF P DN RE N PA S YT YG V ID KD G NV HSH EM HF P DN HG N PS P YS YG I VD KD G NV HSH QM HF S HD HG N PS P YS YG Y ID KN G NM HSH QM HF --D NG N PV D YQ YA Y VD KD G NM QTH EM HF A HD HG N PS P YA YG I VD KD G NI HSH EM HF S HD HG N PS P YA YG I VD KD G NI HSH EM HF S HD HG N PS P YT YG V MD KD G NI VAH EM HF S ED HG N PS P YT YG V MD KD G NI VAH EM LF S ED HG K PS P YT YA I VD KH G NI AHH EM HF P ED HG N PS P YT YG V MD KH G NI VAH EM HF S DD HG N PS P YT YG V MD KH G NI VAH EM HF P ED HG N PS P yt Yg v vd Kd G nl h h eM hF d hg n Ps p EQ AM F YE EF G QY F VS DS F QE DF G QY F -T DS F QE DF G QY F QP TH F YD DF G QY F QP TE F HN DF G QY F QP SH F HD DF G QY F QH AS Y QE DF G QY F VV DQ Y HE DF G QY F AP DH Y YD DF G QY F GG DQ Y FD DF G QY F VM DQ G FE EF G QY F QY DQ T YE DF G QY F VM DP A YE DF G QY F LM DP H FE DF G QY F LM DP H FE DF G QY F MM DP L YE DF G QY F MM DP L YE DF G QY F MM DP H YE DF G QY F MM DP N YE DF G QY F MM DP L YE DF G QY F vv d f ye dF G QY F P PP PP P P PS NS -P AS HS -Q PV AP -A PT QS -V PA HP -V PA HP -T QI HP -P PV HP -T PV HP -P PV SS -P PV TS -P PV PS -P PV NS -P PV NS -V PV NS -V PV NP -P PV NS -P PV NS -P PV NSp pv s HE HS S MF GS I DQ NAQ ----P TG YVQ Y -----MF GS M DP SM-------V YSP F -----MF GS M DP SI-------G YSP Y ---Q S MF GS F DP NT-----I NV YQP Y -----MF GS F DA T---------YQS Y -----MF GS F DT LY----------Q Y -----MF GN F DT LY----------Q Y -----MF GS F DV SN-------Y SQQ Y -----VF GS L DA VS-------C YSE Y -----MF GS L DM MN------CY SQQ Y -----ML GS F DM TSM ----N QT YVQ Y -----VF GS F DV TPM ----N PG YVQ Y -----VL GS F DM SAM ----N QN YMP Y -----VF GS F DI SMN NI VN N EQ YPQ Y -----VF GS F DI SMN NI VN N EQ YPQ Y -----MF GN F DM SM-----N QN YLQ Y -----MF GS F DM
